The PLUS stock exchange today announced volumes in January which started the year off with strong gains. During the month, reported flow on the exchange’s quote-driven platform reached 471,098 trades, a 24% increase on previous month. Trade value was up by 30% at £3 billion, while number of shares increased 26% to 6.17 billion against December 2009.
The exchange has been seeing continued progress in retail flow with volumes growing year on year, as more retail investors return to the markets. For example, in comparison with the previous January, PLUS posted an increase of 23% by number of shares. Other trading highlights for the month include notable market share* in a wide range of stocks, such as:
Stock |
Name |
Market Share
% in trades
(January 2010)* |
AIM |
NEUROPHARM GROUP ORD |
76.56% |
AIM |
SHARE ORD |
77.44% |
AIM |
THORPE F W ORD |
83.23% |
FTSE Fledgling |
CARCLO ORD |
60.85% |
FTSE Fledgling |
SUPERGLASS HOLDINGS ORD |
63.11% |
FTSE Fledgling |
ASTERAND ORD |
65.63% |
FTSE 100 |
CADBURY ORD |
3.46% |
FTSE 100 |
LLOYDS BNK GRP ORD |
3.73% |
FTSE 100 |
ROYAL BK OF SCOT ORD |
6.00% |
Previously, the retail exchange announced executive and board changes**. Cyril Théret, Business Development Director, becomes Chief Executive Officer, while CEO Simon Brickles is appointed Vice-chairman. Giles Vardey is appointed Chairman of the exchange. Vardey’s considerable experience includes serving on the main board of the London Stock Exchange between 1992 and 1997.
PLUS has been seeing a number of positive developments amidst the volatile, evolving markets – working with participants who are making the exchange a more competitive market-maker environment.
Incoming Business Development Director at PLUS, Rachel Maguire said: “Flow on our market has remained strong despite challenging market conditions. This consistent activity provides very strong foundations for PLUS as we look to further enhance our trading services offering.”
* On-exchange trades (data from Netbuilder)
** http://www.plusmarketsgroup.com/PLUS_news_story.shtml?NewsID=1585931&ISIN=GB0032654641/GBX/PLUS-exn